ubenimex has been researched along with Colorectal Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Bar, FM; Amer, MM; Badria, FA; El-Naggar, MH; Mira, A; Shimizu, K | 1 |
| Chen, SZ; Li, G; Ni, J; Shang, Y; Wang, A; Wang, C; Wang, W | 1 |
| Hua, Y; Qiu, L; Wang, J; Wang, Y; Wu, S; Yang, L; Yu, L; Zeng, S; Zheng, X | 1 |
| Bai, R; Bode, AM; Chen, H; Dong, Z; Guo, Z; Jin, G; Li, D; Liu, K; Shin, SH; Wang, G; Wu, Q; Yan, M; Yao, K; Zhao, S | 1 |
4 other study(ies) available for ubenimex and Colorectal Neoplasms
| Article | Year |
|---|---|
Synthesis, docking, cytotoxicity, and LTA
Topics: Aminopeptidases; Antineoplastic Agents; Catechols; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoxide Hydrolases; Fatty Alcohols; Humans; Molecular Docking Simulation; Molecular Structure; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |
Thymidine Kinase 1 Mediates the Synergistic Antitumor Activity of Ubenimex and Celecoxib via Regulation of Cell Cycle in Colorectal Cancer.
Topics: Apoptosis; Celecoxib; Cell Cycle; Colorectal Neoplasms; Humans; Leucine; RNA, Messenger; Thymidine Kinase | 2022 |
Epigenetic regulation of intestinal peptide transporter PEPT1 as a potential strategy for colorectal cancer sensitization.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colorectal Neoplasms; DNA Methylation; Drug Resistance, Neoplasm; Drug Synergism; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Intestinal Mucosa; Leucine; Mice; Mice, Inbred BALB C; Mice, Nude; Peptide Transporter 1; Vorinostat; Xenograft Model Antitumor Assays | 2021 |
Inhibition of LTA4H by bestatin in human and mouse colorectal cancer.
Topics: Adult; Aged; Animals; Antibiotics, Antineoplastic; Biomarkers; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Epoxide Hydrolases; Female; Gene Expression; Humans; Immunohistochemistry; Leucine; Male; Mice; Mice, Knockout; Middle Aged; Models, Biological; Neoplasm Staging; Prognosis; Receptors, Leukotriene B4; Signal Transduction; Xenograft Model Antitumor Assays | 2019 |